Predictive Oncology (NASDAQ:AGPU) Posts Earnings Results

Predictive Oncology (NASDAQ:AGPU) announced its earnings results on Tuesday. The company reported $122.75 earnings per share for the quarter, FiscalAI reports. The business had revenue of $0.01 million for the quarter.

Predictive Oncology Stock Up 10.2%

AGPU stock opened at $1.62 on Wednesday. The firm has a 50-day moving average of $2.13. The firm has a market cap of $5.49 million, a price-to-earnings ratio of -0.12 and a beta of 1.40. Predictive Oncology has a 1 year low of $1.03 and a 1 year high of $32.10.

Wall Street Analyst Weigh In

Separately, Weiss Ratings began coverage on shares of Predictive Oncology in a research report on Monday, January 26th. They issued a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About Predictive Oncology

Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.

Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.